Delivery Order SPE2DB22D2103-SPE2DB25FR8PH

Award Date 12/4/24
Potential Completion Date 12/26/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR8PH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,184.14 Firm Fixed Price contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The specific delivery order is for 4,566,614,658 units of the drug IBRANCE 125 MG CAPSULE 21S, with a performance period through December 26, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and as a major pharmaceutical distributor, the company plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 3/9/25, 12:58 AM